Taysha Gene Therapies, Inc.
NASDAQ:TSHA
2.39 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 144.389 | 87.88 | 149.103 | 251.253 | 0 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 144.389 | 87.88 | 149.103 | 251.253 | 0 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.798 | 8.537 | 10.499 | 6.626 | 0.015 |
| Total Current Assets
| 149.187 | 96.417 | 159.602 | 251.253 | 0.015 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 20.408 | 25.906 | 50.61 | 0.287 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | -4.992 | 0 | 0 | 0 |
| Long Term Investments
| 2.151 | 2.637 | 2.637 | 0 | 0 |
| Tax Assets
| 94.263 | 2.355 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.985 | 3.953 | 1.107 | 7.341 | 0.015 |
| Total Non-Current Assets
| 117.807 | 29.859 | 54.354 | 7.628 | 0.015 |
| Total Assets
| 266.994 | 126.276 | 213.956 | 258.881 | 0.015 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 6.366 | 10.946 | 21.763 | 1.994 | 0 |
| Short Term Debt
| 1.646 | 1.521 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 18.106 | 33.557 | 0 | 0 | 0 |
| Other Current Liabilities
| 4.272 | 5.82 | 8.22 | 3.141 | 0.15 |
| Total Current Liabilities
| 36.756 | 62.79 | 51.746 | 7.129 | 0.15 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 40.508 | 58.407 | 63.092 | 0 | 0 |
| Deferred Revenue Non-Current
| 18.953 | -2.355 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 94.263 | 2.355 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 1.577 | 4.13 | 3.735 | 0.45 | 0 |
| Total Non-Current Liabilities
| 155.301 | 62.537 | 66.827 | 0.45 | 0 |
| Total Liabilities
| 192.057 | 125.327 | 118.573 | 7.579 | 0.15 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.002 | 0.001 | 0 | 0 | 0 |
| Retained Earnings
| -513.007 | -401.441 | -235.649 | -61.126 | -1.115 |
| Accumulated Other Comprehensive Income/Loss
| -0 | -0 | 0 | -0 | 0 |
| Other Total Stockholders Equity
| 587.942 | 402.389 | 331.032 | 312.428 | 0.98 |
| Total Shareholders Equity
| 74.937 | 0.949 | 95.383 | 251.302 | -0.135 |
| Total Equity
| 74.937 | 0.949 | 95.383 | 251.302 | -0.135 |
| Total Liabilities & Shareholders Equity
| 266.994 | 126.276 | 213.956 | 258.881 | 0.015 |